ES3056339T3 - Sulfonylurea derivatives and uses thereof - Google Patents

Sulfonylurea derivatives and uses thereof

Info

Publication number
ES3056339T3
ES3056339T3 ES20733705T ES20733705T ES3056339T3 ES 3056339 T3 ES3056339 T3 ES 3056339T3 ES 20733705 T ES20733705 T ES 20733705T ES 20733705 T ES20733705 T ES 20733705T ES 3056339 T3 ES3056339 T3 ES 3056339T3
Authority
ES
Spain
Prior art keywords
examples
alkyl
optionally substituted
compound
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES20733705T
Other languages
English (en)
Spanish (es)
Inventor
Mark G Bock
David Harrison
Jane E Scanlon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nodthera Ltd
Original Assignee
Nodthera Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nodthera Ltd filed Critical Nodthera Ltd
Application granted granted Critical
Publication of ES3056339T3 publication Critical patent/ES3056339T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
ES20733705T 2019-06-12 2020-06-11 Sulfonylurea derivatives and uses thereof Active ES3056339T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962860664P 2019-06-12 2019-06-12
PCT/EP2020/066185 WO2020249664A1 (en) 2019-06-12 2020-06-11 Sulfonylurea derivatives and uses thereof

Publications (1)

Publication Number Publication Date
ES3056339T3 true ES3056339T3 (en) 2026-02-19

Family

ID=71108562

Family Applications (1)

Application Number Title Priority Date Filing Date
ES20733705T Active ES3056339T3 (en) 2019-06-12 2020-06-11 Sulfonylurea derivatives and uses thereof

Country Status (6)

Country Link
US (1) US20230083495A1 (https=)
EP (1) EP3983407B1 (https=)
JP (1) JP7661248B2 (https=)
CN (1) CN114222739B (https=)
ES (1) ES3056339T3 (https=)
WO (1) WO2020249664A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
PL3983387T3 (pl) 2019-06-12 2024-08-19 NodThera Limited Pochodne sulfonylomocznika i ich zastosowania
CN117279903A (zh) * 2021-02-10 2023-12-22 杭州英创医药科技有限公司 作为nlrp3抑制剂的化合物
EP4729514A1 (en) 2023-06-14 2026-04-22 Haisco Pharmaceutical Group Co., Ltd. Bicyclic derivative parp inhibitor and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS60214785A (ja) * 1984-03-27 1985-10-28 Nissan Chem Ind Ltd ピラゾ−ルスルホニルウレア誘導体、および植物生長調節剤または除草剤
DE4039734A1 (de) * 1990-12-13 1992-06-17 Basf Ag Substituierte 2-aminothiophene enthaltende herbizide mittel
DE4217719A1 (de) * 1992-05-29 1993-12-02 Bayer Ag Zweifach heterocyclisch substituierte Sulfonylamino(thio)carbonylverbindungen
JP3355237B2 (ja) * 1993-10-15 2002-12-09 呉羽化学工業株式会社 N−(置換アミノ)ピロール誘導体、その製造方法及び除草剤
JPH0827147A (ja) * 1994-07-20 1996-01-30 Kureha Chem Ind Co Ltd N−(置換アミノ)イミド誘導体、その製造方法及び除草剤
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
JP2019512009A (ja) * 2016-02-16 2019-05-09 ザ・ユニバーシティ・オブ・クイーンズランド スルホニルウレアおよび関連化合物ならびにこれらの利用
EP3272739A1 (en) * 2016-07-20 2018-01-24 NodThera Limited Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
GB201721185D0 (en) * 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
KR20210053910A (ko) * 2018-08-15 2021-05-12 인플라좀 리미티드 신규한 설폰아마이드유레아 화합물
GB201902327D0 (en) * 2019-02-20 2019-04-03 Inflazome Ltd Novel compounds

Also Published As

Publication number Publication date
US20230083495A1 (en) 2023-03-16
JP2022536160A (ja) 2022-08-12
JP7661248B2 (ja) 2025-04-14
EP3983407A1 (en) 2022-04-20
CN114222739A (zh) 2022-03-22
WO2020249664A1 (en) 2020-12-17
EP3983407C0 (en) 2025-11-12
CN114222739B (zh) 2025-02-11
EP3983407B1 (en) 2025-11-12

Similar Documents

Publication Publication Date Title
KR102735310B1 (ko) Nlrp3 인플라마좀 조절제로서의 설포닐 우레아 유도체
EP3661921B1 (en) Selective inhibitors of nlrp3 inflammasome
ES3056339T3 (en) Sulfonylurea derivatives and uses thereof
KR20230061505A (ko) 알킬-옥사사이클로알킬 모이어티를 함유하는 설파모일 우레아 유도체 및 이의 용도
ES2983661T3 (es) Derivados de sulfonilurea y usos de los mismos
JP2022535955A (ja) スルホンアミド誘導体及びその使用
EA047011B1 (ru) Производные сульфонилмочевины в качестве модуляторов nlrp3 инфламмасомы
HK40039990A (en) Sulphonyl urea derivatives as nlrp3 inflammasome modulators
HK40039990B (en) Sulphonyl urea derivatives as nlrp3 inflammasome modulators
HK40031620B (en) Selective inhibitors of nlrp3 inflammasome
HK40031620A (en) Selective inhibitors of nlrp3 inflammasome
HK40041233A (en) Sulphonyl urea derivatives as nlrp3 inflammasome modulators